{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:13:55Z","timestamp":1789823635570,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T00:00:00Z","timestamp":1210118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002109","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T22:40:07Z","timestamp":1210113607000},"page":"e2109","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barr\u00e9 Syndrome"],"prefix":"10.1371","volume":"3","author":[{"given":"Izumi","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Parizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Dorgham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Demeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Bolgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Gorochov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,5,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.","volume":"345","author":"MD Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1345\/aph.1K037","article-title":"Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.","volume":"41","author":"HM G\u00fcrcan","year":"2007","journal-title":"Ann Pharmacother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00019052-200110000-00009","article-title":"Epidemiology of the Guillain-Barr\u00e9 syndrome.","volume":"14","author":"V Govoni","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.53.3.598","article-title":"Prognostic factors of Guillain-Barr\u00e9 syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barr\u00e9 Study Group.","volume":"53","author":"LH Visser","year":"1999","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome.","volume":"6","author":"R van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group.","volume":"326","author":"FG van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome.","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome.","author":"AK Asbury","year":"1990","journal-title":"Ann Neurol 27 Suppl"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP).","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"ref10","first-page":"1536","article-title":"Myasthenia gravis and related disorders of the neuromuscular junction.","author":"M Victor","year":"2001"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.","volume":"56","author":"A Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy.","volume":"2","author":"RA Hughes","year":"1978","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells.","volume":"188","author":"U Klein","year":"1998","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.","volume":"165","author":"M Odendahl","year":"2000","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2004-07-2507","article-title":"Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.","volume":"105","author":"M Odendahl","year":"2005","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V99.6.2154","article-title":"The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression.","volume":"99","author":"F Medina","year":"2002","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.170.3.1136","article-title":"Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.","volume":"170","author":"T Nakayama","year":"2003","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1182\/blood-2004-08-2992","article-title":"Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells.","volume":"105","author":"G Muehlinghaus","year":"2005","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4049\/jimmunol.118.4.1480","article-title":"Detection of plaque-forming cells in the peripheral blood of actively immunized humans.","volume":"118","author":"PD Thomson","year":"1977","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.4049\/jimmunol.122.6.2498","article-title":"Characterization of a circulating subpopulation of spontaneous antitetanus antibody producing cells following in vivo booster immunization.","volume":"122","author":"RHME Stevens","year":"1979","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.","volume":"128","author":"S Cepok","year":"2005","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barr\u00e9 syndrome.","volume":"101","author":"N Yuki","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell.","volume":"6","author":"A Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells.","volume":"298","author":"NL Bernasconi","year":"2002","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1416","article-title":"Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.","volume":"12","author":"V Siragam","year":"2006","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20061788","article-title":"The antiinflammatory activity of IgG: the intravenous IgG paradox.","volume":"204","author":"F Nimmerjahn","year":"2007","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpneuro0376","article-title":"Drug Insight: the use of intravenous immunoglobulin in neurology\u2013therapeutic considerations and practical issues.","volume":"3","author":"R Gold","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.","volume":"8","author":"Z Xiang","year":"2007","journal-title":"Nat Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni0407-337","article-title":"Killing some to make way for others.","volume":"8","author":"JV Ravetch","year":"2007","journal-title":"Nat Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice.","volume":"199","author":"BF Hoyer","year":"2004","journal-title":"J Exp Med"},{"key":"ref31","first-page":"586","article-title":"Double-blind trial of intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome.","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomized trial.","volume":"363","author":"R van Koningsveld","year":"2004","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543784.13.8.1019","article-title":"Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy.","volume":"13","author":"AR Ahmed","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2002-06-1684","article-title":"Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG.","volume":"101","author":"MJ de Grandmont","year":"2003","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2436::AID-IMMU2436>3.0.CO;2-9","article-title":"Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice.","volume":"29","author":"T Vassilev","year":"1999","journal-title":"Eur J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T05:33:09Z","timestamp":1684387989000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002109"}},"subtitle":[],"editor":[{"given":"Fu-Sheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,5,7]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,5,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002109","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,7]]}}}